The European Health Innovation Collaborative
Dr Martin Abendroth
During his specialist training in internal medicine and later on nephrology he worked in several major German University Hospitals (Münster, Hamburg, Berlin). Emergency medicine has always been one of his major working fields within the last years. His special interest is in improving the quality of medical treatment by improving the education and training of students and young doctors. Furthermore new technologies offer options to enhance patient care in outpatient treatment, rural areas and emergency medicine. Developing concepts and integrating those into every day patient care is also one of his aims.
Specialist in Internal Medicine
Editor, BMJ Open
Adrian Aldcroft is the Editor of BMJ Open, an open access general medical journal that promotes transparency in the publication process by publishing reviewer reports and previous versions of the manuscript alongside the published article. Adrian has also worked as a staff editor on PLOS ONE and as a Senior Executive Editor on the BMC Series. Prior to working in publishing, Adrian spent several years at The University of Western Ontario conducting research using fMRI to map the functional areas of the visual cortex.
Dr. Naila Arebi
Chair of Gastroenterlogy, St Marks
Dr Naila Arebi graduated as a Doctor of Medicine from the University of Malta. She pursued her post-graduate training in Oxford and London leading to accreditation in Gastroenterology. Following her appointment as a consultant Gastroenterologist at St Mark's Hospital and an honorary senior lecturer at Imperial College in 2005, she became a Fellow of the Royal College Physicians in 2010. Her clinical work involved most aspects of gastroenterology with key interest areas Inflammatory Bowel Disease, Irritable Bowel Syndrome and constipation. She currently holds the chair of Gastroenterology for St Mark’s and through the award of NIHR grant. Her current research is focused on Inflammatory Bowel Disease, where she is the chief investigator on a number of research studies aimed at enhancing our understanding Inflammatory bowel disease, testing new treatments and improving the delivery care for patients through national and international collaborations with Chicago, New York and Denmark. She is a reviewer for a number of international journals and grant funding bodies and an author on several peer-reviewed publications. On a national level she sits on the British Society of Gastroenterology adolescents and young adults committee as elected committee member.
Mr Omer Aziz
Consultant colorectal surgeon at The Christie
Mr. Aziz is a consultant colorectal surgeon at The Christie, one of Europe's largest comprehensive cancer centres. At the Colorectal and Peritoneal Oncology Centre he specialises in colorectal cancer (primary, advanced, and recurrent disease), anal cancer, appendix tumours, peritoneal tumours, and coloproctology. He is experienced in open and laparoscopic cytoreductive surgery with hyperthermic intra-peritoneal chemotherapy (HIPEC), advanced laparoscopic techniques, and endoscopic procedures. To date, he has been involved in the development of evidence synthesis techniques to guide healthcare decision-making and published over 100 peer-reviewed research papers, some of which have been used by institutions such as the National Institute for Health and Care Excellence (NICE) in their guidance. He has raised research grants from Innovate UK, the Medical Research Council and the National Institute for Health Research as well as industry investment to translate innovative technologies into medical devices that improve outcomes for patients undergoing cancer treatment.
Ashley Barnabas attended the University of Natal in Durban, South Africa. He trained as a gastroenterologist in south London before further specialist training in liver disease in Oxford and at King's College Hospital. He then worked as a senior clinical research fellow and locum consultant at King's. During this time he was involved in phase 2 and 3 clinical trials of all of the hepatitis C drugs currently in use today. He helped develop a value based model to understand the patient perspective of viral hepatitis treatment. He currently works as a consultant hepatolgist at St Mark's , where he is the clinical lead for the hepatitis C treatment programme
Consultant Hepatologist, St Marks
Dr Helge Bastian
Vice-President & General Manager, Thermo Fisher Scientific
Dr. Bastian has over 24 years of international leadership experience in leading life science & healthcare corporations serving governmental, academic, biomedical, diagnostic, pharmaceutical, biopharmaceutical, and applied research laboratories and their companies with innovative products and service solutions.
Dr. Bastian earned his diploma in biology (biochemistry) from Georg-August University Goettingen, and holds a Ph.D. in molecular biology pursued at the Max-Planck Institute for Biophysical Chemistry in Goettingen, Germany.
Today, Dr. Bastian leads the Synthetic Biology business as Vice President & General Manager at Thermo Fisher Scientific, the world leader in serving science, with revenues of $17 billion and more than 50,000 employees in 50 countries, out of Carlsbad, California, USA. Previously, Dr. Bastian served as Managing Director and Chief Commercial Officer at Indivumed, in Hamburg, Germany, and as Vice President of Global Marketing, Business Development & Strategy Research Biotech and member of the leadership team at Sigma-Aldrich in St. Louis, Missouri, USA. Prior to that, he served as Executive Vice President of the Life Science Services business and member of the Senior Executive Management Team at SGS in Geneva, Switzerland. Dr. Bastian joined SGS after more than 11 years with QIAGEN in Duesseldorf, Germany, where he was a member of the Executive Steering Committee and held various management positions, most recently as Vice President Molecular Diagnostics, Vice President Global Strategic Marketing, Vice President PreAnalytiX.
Andrew has over 25 years’ experience supporting healthcare and other organisations leverage digital assets and opportunities to improve outcomes and drive efficiency through changes in the way that services are delivered. A leader in Optimity’s Digital and Information Management practice, Andrew has a substantial track record of working internationally and locally to personalise care.
Dr. Richard Berman
Dr. Berman graduated in medicine from Charing Cross & Westminster Medical School in 1996. He joined a specialist training programme for palliative medicine in 2002 (Northwest deanery).
Dr Berman now works as Consultant in Supportive Care and Honorary Senior Lecturer at The Christie NHS Foundation Trust, Europe’s largest single-site cancer centre.
His main clinical interest concerns the early involvement of palliative care in cancer care.
Having pioneered a new approach to the delivery of palliative care in a cancer centre, he is now NHS England’s lead clinician for The Enhanced Supportive Care Initiative – a new programme to improve access to specialist supportive care for patients going through cancer treatment.
Honorary Senior Lecturer, The Christie
Prof Ann Blandford
Ann Blandford is Professor of Human–Computer Interaction at University College London and Director of the UCL Institute of Digital Health. She is an expert on human factors for health technologies, and particularly on how to design systems that fit well in their context of use. She is involved in several research projects studying health technology design, patient safety and user experience. These include both hospital and home technologies, for use by professionals and the rest of us. The question that motivates her research is: how can we design and deploy health technology that really works for people, rather than technology that forces us into undesirable modes of working, that causes stress, or that is rejected as not being fit for purpose? She has published widely on the design and use of interactive health technologies, and on how technology can be designed to better support people’s needs and values.
Honorary Senior Lecturer, The Christie
Dr. Mamta Buch
The Christie NHS Trust, Manchester
Dr. Buch's cardiology and interventional training was undertaken in Manchester and Cedars-Sinai Heart Institute, Los Angeles. Her formal research training includes a Ph.D. in molecular biology at the University of Manchester and a one-year post-doctoral position at the Regenerative Medicine Institute at Cedars-Sinai in Los Angeles. Dr. Buch has a particular expertise in structural cardiac interventions, and leads the MitraClip CtE User Group in England. She contributes to national cardiac and interventional cardiology meetings. Her research interests include coronary artery disease, valvular heart disease, and translational cardiac regenerative medicine.
Dr Yasmin Buchaekert
Yasmin originally trained as a vet before embarking on a successful research career. She studied under the world-renowned pulmonologist, Prof. Werner Seeger, at the University of Giessen, GErmany. Here she completed her PhD as part of a graduate programme concentrating on molecular biology and medicine of the lung. Yasmin’s research focus was ARDS/Acute Lung Injury. Along the way she spoke at prestigious meetings, worked on high-profile projects and co-authored a number of interesting publications.
Following completion of her PhD, Yasmin moved to the commercial world, first working in the field of oral and maxillofacial surgery where she led a team developing innovative products made from human bone transplants. The goal was to bring to market minimal invasive bone augmentation techniques which did not necessitate autografting. Subsequently, Yasmin moved to internal medicine/oncology at Epigenomics. Here her role is to inform healthcare professional across Europe as to the potential benefits of new biotechnologies, notably liquid biopsy, for the early diagnosis of cancer.
Chris is a renowned specialist in cancer data and information, but with a particular focus on patient involvement and patient power.
Chris was a founding member of the National Cancer Intelligence Network (NCIN), a partnership funded by a range of bodies, including the public sector and leading cancer charities, tasked with providing new insights and intelligence into cancer inequalities, diagnosis, care, outcomes and experience, putting patients at the heart of how their data is used.
In 2014 he was named as one of the Health Service Journal’s Top 50 Innovators in the NHS for his innovative and collaborative approach to patient empowerment, and also featured on BBC Radio 4’s Networking Nation series, where the NCIN was highlighted as a leading example of how best a network can operate.
Chris is currently working on the use MY data patient programme and remains passionate about actively involving patients in everything that is done in their name.
Prior to the NCIN, Chris worked on areas of national cancer programmes for 10 years, including 5 years as the National Coordinator for Cancer Registration in England, and internationally as part of an expert group on automated cancer registration, and of a European review team looking at registration in Europe.
Chris has a comprehensive background in health informatics, with a particular focus on cancer informatics. He has played a pivotal role in several national initiatives around health informatics to drive outcomes, not least the world-leading Routes to Diagnosis programme.
National Cancer Intelligence Network
Dr. Beatrix Doerr
European Medical Writers Association(EMWA)
Beatrix originally trained as a vet. Subsequently, she became involved in clinical research, holding increasingly senior roles. One of her major contributions was to lead a number of high-profile clinical research departments across Europe who’s role was to successfully develop transcatheter heart valves.
In 2011 Beatrix established her own company, CORIUVAR which focuses on clinical research consulting and medical writing for medical devices.
More recently, Beatrix was elected as an executive committee member of EMWA and took up the role of public relations officer. Among her many responsibilities, Beatrix and her team look after social media, promotion and advertisement, cross-functional relationships and the Internship Forum for new writers.
Dr Mo Dewji
Hilltops Medical Centre
Dr Mo Dewji is a partner and trainer at Hilltops Medical Centre. He studied initially in North London and undertook his medical degree at Guys Hospital - a part of the Kings Hospital Group in London. He then worked at the Charing Cross Campus of Imperial College and studied surgery under the Professor Greenhalgh’s team. Then, he moved to North Buckinghamshire and completed his VTS training prior to becoming one of the principal partners at Hilltops. His clinical expertise lies in Paediatrics, which he practised as a Hospital Practitioner for 11 years.
He continues to be associated with the Great Ormond Street Hospital Paediatric Update Program. Other interests include minor surgery, Sigmoidoscopy and teaching - the latter of which he does within the guise of the Oxford deanery. Away from his clinical expertise, Dr Dewji was previously the Chair of the Professional Executive of Milton Keynes Primary Care Trust and since the turn of the century has been a senior advisor to the Department of Health within England. He also acts as a Clinical Director within the Improvement Foundation, an organisation that develops and delivers programs aimed at delivering the highest quality of care within an optimal patient pathway.
Other senior positions held by Dr Dewji includes Head of The National PMS Development Team, Founder and member of the National Resource Framework Group as well as Clinical Advisor to the NICE Commissioning Board. Dewji also spends a lot of his time working for and with the community as well as volunteering. He was one of the medical team that worked with Doctors Worldwide and the Commonwealth Foundation within Sri Lanka and Maldives following the Tsunami.
Public Involvement Lead, Research Authority, carer and editorial board, Research Involvement and Engagement.
Jim provides leadership to the Health Research Authority on the involvement of patients and the public in health research [part time] as part of his work as advocate for patients in research. He has been a carer for close family with cancer and other health conditions for many years. His career has been spent in health research management across the commercial, public and voluntary sectors. His combined experiences have led to an interest in helping to ensure that patients and the public can make a contribution to the design, conduct and management of health research. Jim is currently involved as a public contributor in the work of Cancer Research UK and the National Institute for Health Research. His involvement in research also includes being a member of the Consumer Forum of the National Cancer Research Institute, Independent Cancer Patients’ Voice and Health and Care Research Wales’ Involving People Network.
Dr Simon Gabe
Consultant Gastroenterologist at St Mark's
Simon Gabe is a Consultant Gastroenterologist at St Mark's Hospital in Harrow. He Co-Chairs the Nationally commissioned Intestinal Failure service at St Mark’s, one of two centres in the UK currently funded to provide this service. He was appointed as Senior Lecturer at St Mark's and Imperial College in 2000. Since 2005 this has become an NHS appointment. His MD thesis was on intestinal permeability in critical illness and he also has an MSc in Clinical Nutrition.
Dr Gabe has a wide clinical experience in dealing with complex inflammatory bowel disease, especially with fistula development as well as intestinal failure, clinical nutrition, home parenteral nutrition and consideration of intestinal transplantation. He co-founded the National Adult Small Intestinal Transplant Forum together with Addenbrooke’s Hospital and has an honorary contract at Addenbrooke’s as a visiting specialist. Also, he is Caldicott Guardian for North West London Hospitals Trust and in 2010 was appointed to the UK Council of Caldicott Guardians.
Professor Hartmut Gemmeke
Karlsruhe Institute of Technology
Prof. Dr. Hartmut Gemmeke was born in Northeim, Germany, on March 9th, 1944. He received his Ph.D. degree and postdoctoral lecture qualification from the University of Heidelberg, Germany, in 1971 and 1979 respectively. After two years, with the University of Marburg, Germany, he joined 1982 Forschungszentrum Karlsruhe (FZK), where he worked several years on the planning and commissioning of the KARMEN neutrino experiment at Rutherford Appleton Laboratory, England. Since 1990, he was a supernumerary professor at the University of Heidelberg and 1996 at the University of Karlsruhe. 1993 he was head of the Central Department of Electronics and Data Processing at FZK and since 2001, appointed as director to the Institute for Data Processing and Electronics at FZK, now Karlsruhe Institute of Technology (KIT). He was member and head of several committees on electronics, micro system technology, and data processing in Germany and IEEE (RT). He has about 400 publications including 50 in medical engineering. He is now retired and works as senior advisor at the KIT.
His present research activities are focused on the investigation of 3D Ultra Sound Computer-Tomography for early breast cancer detection.
Dr Faye Gishen
Royal Free Hospital, London
Dr Faye Gishen is a clinical academic. She is a consultant physician in palliative medicine in North London, treating patients with malignant and non-malignant disease, mainly in the outpatient setting. She has a special interest in cancer survivorship and rehabilitation.
She also has an academic role at University College London. She is responsible for the academic content and delivery of around 20% of the medical school undergraduate curriculum. One of the modules she oversees is Professionalism, and this has led to an interest in promoting resilience in both qualified doctors and doctors in training. One of her aims is to make reflective practice more palatable and interesting to medical students. She has introduced reflective practice Schwartz Rounds into the undergraduate curriculum; the second medical school in the world to do so. She also facilitates Rounds in her clinical workplace.
She is a Fellow of the Royal College of Physicians, London, Fellow of the Academy of Medical Educators and a Senior Fellow of the Higher Education Academy.
Dr. Angela Grainger
Angela Grainger is registered with the UK’s Nursing and Midwifery Council (NMC) as a Lecturer Practitioner, a Registered General Nurse, and a Registered Sick Children’s Nurse.
Angela is a Visiting Professor at London South Bank University, and is a senior lecturer at the Florence Nightingale School of Nursing & Midwifery, at King’s College London. She is also an associate academic at BPP University. Angela has published for over 30 years and is also the author of two books. Angela was a joint founder of the British Journal for Health and now acts as consultant editor.
Angela’s PhD thesis entitled “Fit for Nursing?” explored the employability of registered nurses who have a physical impairment in the acute sector of the NHS.
Angela is Assistant Director of Nursing at King’s College Hospital NHS Foundation Trust where she has the lead role for Nurse Education & Research. As well as academic posts Angela has held several senior management posts in the NHS and she continues to practice in both adult and paediatric trauma.
Assistant Director of Nursing, King’s College Hospital NHS Foundation Trust
Dr Antke Hagena
Consultant in palliative medicine at North Middlesex University Hospital and Marie Curie Hospice Hampstead
Dr Hagena graduated in medicine at Luebeck Medical School in Germany, where she also completed a MD, in 1996. She moved from a medical training post in Germany to London in 1999 after developing an interest in palliative medicine, became a member of the Royal College of Physicians in 2002, and completed specialist training in palliative medicine in 2013.
She has worked as a consultant in palliative medicine in Norden, Germany, in 2009-2011, where she set up a new Palliative Care Service for the region. Since 2013 Dr Hagena is working at Marie Curie Hospice Hampstead, and since 2014 also at North Middlesex University Hospital in North London.
Her special interests are equitable access to palliative care services and integration into acute medicine.
In the first dot-com boom, Harry helped take an Internet security start up from 3 employees to acquisition by Sun Microsystems. Since leaving software marketing, he’s been helping organisations think about how their objectives relate to their peoples, designing interactions in the resulting projects, and making the best decisions possible about the products that come out of them. He occasionally speaks at conferences, usually about the things he's learned about making developing software less painful and more effective. He's particularly proud of his work on Neontribe's projects for social good: Mind Of My Own, Doc Ready and the Great British Public Toilet Map amongst others.
Deputy Editor for BioMed Central's Genome Medicine
Maria Hodges is the Acting Chief Editor of Genome Medicine, a flagship publication of BioMed Central. She has a BSc in Biochemistry from Imperial College London and a PhD from the Imperial Cancer Research Fund (now Cancer Research UK). For her PhD, Maria investigated mechanisms of relapse after treatment in acute promyelocytic leukaemia. She has also researched at the Pasteur Institute, Paris. Before moving to BioMed Central, Maria was an editor for Nature Structural and Molecular Biology.
Professor Andrew Krentz
Andrew Krentz (MD FRCP) is Professor of Endocrinology & Metabolism and Director of the Institute of Translational Medicine in the Clore Life Sciences Laboratory, University of Buckingham, UK. He is also Senior Research Fellow at Profil Institute for Clinical Research in San Diego, USA and a Clinical Instructor in the Department of Family & Preventive Medicine at the University of California San Diego, USA.
Senior positions have included: Visiting Professor of Medicine at Bedfordshire & Hertfordshire Postgraduate Medical School, University of Bedfordshire, UK; Consultant Physician in Diabetes & Endocrinology, Southampton University Hospitals, UK; Senior Clinical Lecturer, the University of Southampton UK.
His clinical research training in human metabolism was undertaken in Birmingham, UK and the University of New Mexico School of Medicine, Albuquerque, USA. His postgraduate doctoral thesis was titled 'Metabolic Studies in Insulin Resistance'. In 2004-5 he was the recipient of a British Heart Foundation International Research Fellow at the University of California San Diego, USA.
His textbooks include Insulin Resistance: A Clinical Handbook (2002); The Metabolic Syndrome & Cardiovascular Disease (2007); Translational Methods for Diabetes, Obesity and Cardiometabolic Drug Development: Focus on Early Phase Clinical Studies (2015). Professor Krentz has served as national Council member on the Section of Lipids, Metabolism & Vascular Disease of the Royal Society of Medicine, UK and he is accredited as a clinical specialist by the European Society for Hypertension.
He has been a member of the editorial boards of journals including Diabetes Obesity & Metabolism, Diabetes and Vascular Disease Research, Diabetic Medicine and is a faculty member at the ‘Faculty of 1000’. In 2012 he founded a new international scientific journal – Cardiovascular Endocrinology – as Editor-in-Chief.
Clore Life Sciences Laboratory, Uni. of Buckingham
Ordained an Anglican priest in 1975, I have worked as a psychiatric social worker, chartered psychologist, psychology lecturer, social work tutor and practice supervisor. However, an important part of my working life has been in healthcare chaplaincy, initially leading a team in a South London psychiatric hospital before moving to Devon where, after university and local authority jobs, I managed a department of pastoral and spiritual care at Derriford Hospital, in Plymouth, for ten years. Returning to London in 2011, I was appointed palliative care chaplain to Imperial College Healthcare NHS Trust before joining Westminster Abbey as chaplain and priest vicar. Last year, I became spiritual & religious care lead at Marie Curie Hospice Hampstead while continuing a priest vicar at Westminster Abbey. Devon remains a special place where at Exeter University I am completing a PhD and at Exeter Cathedral I am a Prebendary Emeritus.
Marie Curie UK
Dr Stephen Lawrence
Primary Care Diabetes Advisor to Diabetes UK; Lecturer at the University of Warwick Medical School; Clinical Lead on Diabetes for the Royal College of General Practitioners
Dr. Stephen Lawrence is a Primary Care Clinical Lead in Chatham. He graduated from Leeds University Medical School in 1987. His interest in metabolic medicine was awakened when he completed a BSc (Hons) degree in Chemical Pathology during his intercalated year. He has previously worked as a Medical Advisor for Prisons at the Department of Health, where he participated in an award-winning prison diabetes study. His interests include critical appraisal of evidence-based medicine and diabetes commissioning and service development. He has presented to healthcare audiences throughout the UK and beyond. In 2003, Stephen was instrumental in establishing an intermediate-care GP with a Special Interest in Diabetes clinic in Medway in answer to the burgeoning burden of diabetes referrals to the local Medway Maritime Hospital. He has written articles on the evolving role of community-based diabetes care. He trains healthcare professionals wishing to advance to supplementary or independent prescribing status. In addition, he has served in a joint role of Primary Care Medical Advisor for Diabetes UK and Clinical Diabetes Lead for the Royal College of General Practitioners. He is a Lecturer at the University of Warwick Medical School.
Dr Bernd A. Leidel
Charité Universitätsmedizin Berlin
Bernd A. LEIDEL M.D., is vice head of the Department of Emergency Medicine at Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin, Germany.
Following his training in Emergency Medicine, Trauma and Surgery at Klinikum der Universität München, Germany and working for EMS and HEMS as well, he had also a chance to work for HEMS and in retrieval medicine in Australia before switching to Berlin in 2009. He is enthusiastic about emergency medicine and very much interested in providing training and care in the hospital and prehospital arena.
Professor Andrew Lewis
Professor Lewis is the Director of Research and Development at Biocompatibles UK Ltd. He specialises in the development of advanced biomedical polymer systems, which have been applied to novel drug-device combination products for the treatment of cardiovascular disease and cancer. He was co-inventor of the Drug Eluting Bead, a novel drug delivery system which is available in over 600 hospitals in 50 different countries, with over 100,000 reported procedures to date. This product won the PLC Best Technology Award in 2003 and in 2011 was further recognised by the Prince Philip Award for Plastics in the Service of Mankind He has published over 200 papers and contributed chapters to many textbooks, including Biomaterials for Cancer Therapeutics (2013), Tumors of the Central Nervous System (2012) and Handbook of Stents (2001).
University of Brighton, Biocompatibles
Dr Marion Lynch
Dr. Marion Lynch is Deputy Medical Director for NHS England South Central, the middle of England from the M25 to Wales. She is responsible for leading the systems and processes which assure the public that GPs are up to date and fit to practise. She is also a national innovation ‘thought leader ’and strategic lead, contributing to defining and designing the future workforce our patients deserve and the services they will need. She has worked in the NHS and aboard for 35 years. She believes in a state-supported health and wellbeing system which enables people to look after and improve their health and cares for them when this is no longer possible. Her doctorate challenged the current approaches to medical education and the expected outcomes. She races big sailing boats which results in big bruises and small wins. She originally trained as a nurse and a public health specialist.
NHS Thames Valley & Wessex Leadership Academy
Omar Mahroo is currently working as a Locum Consultant Ophthalmologist at Moorfields Eye Hospital and St Thomas' Hospital, and conducts research at University College London, King's College London and the University of Cambridge. He has a strong research interest in retinal electrophysiology – recording the electrical signals generated by the retina in response to light. These signals are processed in the retina and transmitted to the brain allowing us to see. He completed a PhD in this subject under Trevor Lamb FRS in the middle of his medical degree at Cambridge, and has published numerous papers since, including co-authoring a recent research letter in the New England Journal of Medicine looking at changes in these signals after viewing a smartphone (helping show that “blindness” after smartphone viewing is harmless and related to retinal adaptation).
Michael is the Associate Publisher at F1000Research, and is a staunch open science and open data advocate. Michael’s main role is to work on devising and implementing innovative ways to improve the uptake of open science practices and improve reproducibility for the scientific community as a whole. He is currently working on the launch of the new funder based publishing platform Wellcome Open Research
Dr Jon Matthews
Chelsea & Westminster Hospitals, London
Jonathan Matthews studied Molecular Medicine at the University of Sussex finishing in 2007 and subsequently went on to study Medicine at the Hull York Medical School graduating in 2012. After completion of his foundation training he undertook 3 months volunteer work improving local healthcare systems in rural Ghana.
Currently he is an Emergency Medicine trainee in North West London and based at Chelsea and Westminster hospital.
His main interests are healthcare innovation and management. Whilst training he has undertaken a number of quality improvement and governance projects and is currently managing a trial to improve nebuliser drug delivery using a novel delivery system.
Ben has worked for 12 years in the information industry, focusing on library technologies and data. He has been at Altmetric as their Product Sales manager since 2014. He previously brought Proquest's Summon to the market in 2010 and has worked at the American Chemical Society and Wiley.
Dr. Ravi Misra
St Mark's Hopital
Ravi is a senior gastroenterology trainee at St. Marks Hospital currently in the second year of his PhD. Ravi’s particular interest is the impact of ethnicity on the incidence, phenotype and microbiome in inflammatory bowel disease.
Chris Miller is an NIHR Clinician Scientist, Senior Lecturer and Honorary Consultant Cardiologist in Manchester, UK. He has a translational research programme which aims to develop novel cardiovascular imaging biomarkers, use these biomarkers to better phenotype cardiovascular health and disease and conduct early phase trials of new interventions using these biomarkers as end points.
Senior Lecturer and Honorary Consultant Cardiologist
Dr. Esther Murray
Queen Mary University London
Dr. Murray is a Chartered and Registered Health Psychologist with an interest in childhood obesity, social inequalities in health and doctor-patient communication. Her early research was in chronic pain and its effect on doctor-patient communication and she has a background in psychological intervention in cardiac care and training NHS staff in communication skills. For the past 5 years, she has run a Master's degree in Health Psychology at London Metropolitan University and now teaches Health Psychology to MBBS students at Barts and the London School of Medicine and Dentistry, Queen Mary University.
Professor Abhay Pandit
National University of Ireland, Galway
Professor Abhay Pandit is the Director of a Centre for Research in Medical Devices (CÚRAM) at the National University of Ireland, Galway. Professor Pandit is one of the world leaders in developing new biomaterials for use in medical devices. The focus of Professor Pandit’s lab is to develop new biomaterials combining synthetic and natural polymers, tailored glycomolecules, small molecules nucleic acids targeting systems and cellular elements for use in structures that can be used in a wide range of surgery and therapy. A key area of his work regards biodegradable materials which will be absorbed into the body over time. The areas of medicine involved are very diverse, ranging from cardiology to neurology and is increasing over time. He has led in the development of targeted controlled-drug-release systems, multi-component biomaterial-based selective delivery systems and the synthesis of electrically responsive materials. He is the author of 4 patents with 18 other patent applications pending and has licensed three technologies to medical device companies. Prof. Pandit has also authored nearly 200 papers in high-impact journals such as Nature Communications and is a member of the editorial board of 13 journals. Some of Professor Pandit’s work has included: ~A polymer for transfecting a nucleic acid into a cell ~Collagen multichannel nerve conduits for use in the repair of nerve injury. ~A polymeric hollow nanosphere for release of biomolecules, therapeutic agents and ~Principal investigator for a tissue-engineered heart valve project. ~He is the director of the 'Network of Excellence for Functional Biomaterials - a Science Foundation Ireland Strategic Research Cluster
Jon joined Medtronic in October 2008 leading the communications function for Medtronic UK & Ireland. Since then Jon has been involved in numerous product launches, established strong relationships with media on behalf of the company, developed partnerships with press teams in hospitals across the UK & Ireland and overseen the development of a social media presence for the company. During his time with the company, the Medtronic team has received the Communique Award (healthcare PR and medical education awards) for In House Team of the Year on two occasions.
In addition to UK & Ireland communications responsibilities he also has PR responsibilities for the Neuromodulation business in EMEAC and also for Hospital Solutions.
Jon has over 15 years of experience in healthcare PR and communications manaing media campaigns for many prescription drugs, Over The Counter treatments and developed disease awareness campaigns for many of the major pharmaceutical companies.
He worked with PR agencies in London and Sydney before setting up on his own supporting clients like the National Rheumatoid Arthritis Society (NRAS), the ABPI and organising the annual Ask About Medicines campaign with the Department of Health.
Jon has BA hons degree in History from the University of Warwick and a Masters in European Industrial Relations from Warwick Business School.
Dr. Maxton Pitcher
Dr Pitcher is a Consultant Gastroenterologist. Max was appointed to the staff at St Mark's and Northwick Park in 1998 from Oxford, where he was Senior Registrar. He graduated in Medical Sciences from the University of Cambridge in 1985 and qualified in 1988 from the University of Oxford. His research on sulphate-reducing bacteria, sulphur metabolism and ulcerative colitis at The MRC Dunn Clinical Nutrition Centre won him a University prize for his MD Thesis in Cambridge in 1996. Max continues to have a clinical research interest in gut flora and inflammatory bowel disease and is a medical advisor to NACC. As well as running a specialist IBD clinic, Max sees general Gastroenterology outpatient referrals and patients with GI cancer. The latter are managed in close collaboration with specialist surgical colleagues as part of the West London Cancer Network. With Dr. Meron Jacyna, he manages the majority of the acute Gastroenterology inpatient workload admitted to Northwick Park Hospital, as well as the therapeutic ERCP service. His "extralumenal" interests include golf, SCUBA diving and playing the violin in chamber ensembles and orchestras including the European Doctors Orchestra.
St Mark's Hospital, Harrow, London.
Charlotte is an Innovation Consultant at Macmillan Cancer Support, designing new services for people living with and beyond cancer. Prior to this she has worked in the UK and overseas leading a range of research, policy and programme development projects. Starting her career as an analyst at KPMG, she quickly moved on to understanding and resolving problems in the public sphere. She has worked in the health sector for the last 10 years. She has a degree in modern languages from the University of Cambridge and a Masters in International Development from the School of Oriental and African Studies.
Harry Roberts is an ophthalmology trainee currently working for an MD at St Thomas’ Hospital and Kings' College London on the use of the Femtosecond laser for cataract surgery within the National Health Service. He has recently passed his ophthalmology fellowship exam, being awarded the Harcourt medal for the top result. He has several publications and has recently co-authored a book.
Dr Patrick Roberts
Patrick trained at Kings College London and worked in a number of hospitals in the South-East, followed by three years in Melbourne, Australia. A Consultant in Emergency Medicine at Chelsea & Westminster Hospital for the last 10 years. His interests include resuscitation, point of care and education.
Chelsea & Westminster Hospitals, London
Dr. Bob Ryder
Consultant Diabetologist, Clinical Lead for Association of British Clinical Diabetologists nationwide diabetes audits, City Hospital, Birmingham
Bob Ryder went to medical school and undertook junior medical and research jobs in South Wales before moving to become Senior Registrar in Sheffield. He has worked as a Consultant Physician with an interest in Diabetes and Endocrinology at City Hospital, Birmingham since 1991. Over the years special interests have included photographic screening for diabetic retinopathy (he undertook much of the groundwork behind the current national eye screening programme); diabetic autonomic neuropathy, diabetic impotence and . He runs the ABCD website and leads the ABCD nationwide audits of new therapies. He is chief investigator for the NIHR supported, multicentre, ABCD Endobarrier study, “REVISE-Diabesity”, and the recently commenced “End-OSA” study of Endobarrier in diabetes with Obstructive Sleep Apnoea. A current major interest is community diabetes and a project which won the QIC best primary and/or community initiative in 2014). Beyond diabetes he is best known for being principle author of the bestselling "An Aid to the MRCP Short Cases".
Dr Mark Saunders
Dr. Mark Saunders is Consultant clinical oncologist at the University of Manchester received his medical degree from Charing Cross Hospital, London, UK, in 1986 and followed this with further training at teaching hospitals in London. He spent 5 years working in general medicine before specialising in oncology, first at the Churchill Hospital in Oxford and later at The Christie in Manchester. During his time as an Imperial Cancer Research Fund Fellow at the Churchill Hospital, Dr. Saunders gained a Medical Research Council (MRC) grant to fund work that led to his Ph.D., entitled “The application of gene therapy to selectively enhance tumour cell kill by bioreductive drugs”, which he completed in 1999. He was the recipient of the Karol Sicher Research Fellowship, awarded by the UK Royal College of Radiologists, which allowed him to spend three months working with Professor Ralph Weichselbaum at the University of Chicago. He was made a consultant at The Christie in 1999. His main area of interest is running clinical trials evaluating novel agents with associated response/toxicity biomarkers and radiology (colorectal cancer, anal cancer, and pseudomyxoma). He has written a series of protocols for clinical trials that have been funded, completed and published. He also chairs or is a member of a number of Trial Management Groups (TMGs) and Data Monitoring Committees (DMCs). Dr. Saunders is a member of a number of NCRN and CRUK committees and chairs the Northern Cancer Drug Fund (CDF) committee. He is also an advisor to Beating Bowel Cancer, a charity dedicated to raising awareness of bowel cancer, improving the quality of life of those affected and, ultimately, reducing deaths from bowel cancer.
The Christie NHS Trust, Manchester
Professor Greg Simons
Greg Simons is professor of Primary care at the University of Buckingham since 2014, where he leads on the GP aspects of curriculum delivery for undergraduate medicine. Professor Simons continues to work as a GP in the market town of Buckingham where he has been based for the last 15 years, having previously served in the Royal Army Medical Corps in operations at home and abroad. In recent times, he has been an associate GP Dean in Oxford with patch responsibility for Milton Keynes and more recently the whole of Buckinghamshire. He has co-led the Educational and Clinical Supervisor training for Hospital Consultants in all the Acute Trusts. His other positions of responsibility include National Clinical Lead on GP Access and Responsiveness, as well as GP Specialist Advisor to the Care Quality Commission.
University of Buckingham
Mr Chelliah Selvasekar
Mr. Selvasekar qualified in Madras, India, followed by specialist registrar training in Manchester. He undertook two years’ of full-time clinical research at University College London on the use of minimally invasive treatment in the management of dysplastic lesions, leading to an MD degree.
Mr. Selvasekar spent a year as an international clinical colorectal fellow at the world renowned Mayo Clinic, Minnesota, USA in order to gain experience in minimally invasive and complex colorectal surgery before returning to completing his surgical training at The Christie Hospital. Along the way, he became an accredited colonoscopist for the national bowel cancer screening programme and now offers regular diagnostic and therapeutic endoscopies.
Mr. Selvasekar established laparoscopic colorectal surgery at the Christie Hospital and at Leighton Hospital, has performed over 300 laparoscopic colorectal resections to date and offers surgical treatment for all aspects of general and colorectal surgery.
With regards to education, Mr. Selvasekar is an ALSGBI recognised preceptor, training colorectal surgeons and specialist registrars in laparoscopic colorectal surgery, and is a national trainer for laparoscopic colorectal surgery through the DoH established LAPCO programme. He holds an honorary lecturer contract with the University of Liverpool. He is a member of the faculty of trainers at the Royal College of Surgeons of Edinburgh and is also an examiner for the MRCS degree.
The Christie NHS Trust, Manchester
Dr Anna Sharman
Anna Sharman did a PhD and postdoc in biology before moving into journal publishing. Having been an editor of several top journals and worked as a freelance consultant, in 2014 she founded Cofactor, which helps researchers in science, technology and medicine to publish their results most effectively. Anna's popular workshops give guidance in how to write and publish a research paper, and Cofactor's team of freelance editors improve papers for authors and journals.
Professor Rajan Somasundaram
Charité Universitätsmedizin Berlin
Prof. Rajan Somasundaram is head of the Department of Emergency Medicine at the Charité Campus Benjamin Franklin in Berlin. At the Charité University Hospital, he worked in internal medicine first and specialised in gastroenterology/hepatology, with his research focus being liver fibrosis/cirrhosis. Later this was paralleled by emergency medicine (EM), which is now his main clinical focus. One of his aims is to contribute to further development of EM as an independent clinical specialty in Germany and thus, to train young doctors in this field even better than before. Furthermore, he is interested in the development of concepts of care for elderly patients in EM.
Sophie Staniszewska leads the Patient and Public Involvement (PPI) and Patient Experiences Programme at the RCN Research Institute, Warwick Medical School, University of Warwick. Previously Sophie was Director of Research at the National Centre for Involvement and Director of Graduate Studies in the School of Health and Social Studies. Sophie is a member of the National Quality Board Patient Experiences Sub-group. Sophie has carried out a wide range of studies. Sophie recently completed a scoping study for NICE which developed the Warwick Patient Experiences Framework that informed the NICE Patient Experiences Guidance. Sophie also led a systematic review of the impact of patient and public involvement on health and social care research, funded by the UKCRC. Sophie is currently working with EQUATOR to develop the first international guidance to enhance the quality of PPI reporting. Sophie also led the POPPY Project which examined parents' experiences of having a pre-term baby (www.poppy-project.org.uk). Sophie recently chaired the NICE Patient Experiences Guideline and Quality Standard. Sophie is a member of the Internal Methods Advisory Group at NICE. Sophie is also a member of the Research Excellence Framework 2014 Public Health, Health Services and Primary Care Panel. Until recently Sophie chaired the Evidence, Knowledge and Learning Group of INVOLVE and was a member of the Main Group of INVOLVE. Sophie is now an INVOLVE Associate having completed her term of office. Sophie is a member of the NETCC PPI Group. Sophie is also a member of the Health Technology Assessment International Patient/Citizen Involvement Steering Group and co-chairs the Methods and Impact Group. Sophie reviews for a range of funding bodies and international journals, is on the editorial board of the International Journal for Quality in HealthCare, Patient Experiences Journal, The Patient: Patient Centered Outcomes Research and supervises a number of PhD students.
Research Involvement and Engagement UK
Richard Stephens is a survivor of two cancers and a heart emergency. He has participated in four clinical trials and several psycho-social and quality of life studies.
Richard Chairs the NCRI’s Consumer Forum and is the NCRI Consumer Lead. He serves on strategic groups for NIHR, NCRAS, MRC CTU, Genomics England and others. He sits on Cancer Research UK’s main funding committees, and was the patient representative on the Independent Cancer Taskforce that produced the 2015 Cancer Strategy for England, Achieving World Class Cancer Outcomes.
Richard was one of the founders of the AllTrials campaign and is a leading member of the useMYdata movement. He is the joint Editor-in-Chief of BioMed central’s Journal of Research Involvement and Engagement, and brings the “slightly uncertain voice of the partly-informed patient” to the Department of Health’s Patient Experience Advisory Group and also has a consultancy role with Astra-Zeneca.
These activities follow on from careers in journalism, teaching, local government (including award-winning innovative approaches to rent collection and to social housing allocation), and as a school governor specialising in turning around poorly-performing schools.
Dr. Claire Stocker
Senior Research Fellow, Clore Life Sciences, University of Buckingham
Claire was awarded her BSc (Hons) Biochemistry from the University of Southampton and a PhD from Imperial College, London and has worked in the pharmaceutical industry for three years. She was awarded the IASO New Investigator Award in 2002 shortly after joining the School of Science and Medicine. Claire is the Deputy Chairman for the School Ethics Committee and the Research Officer for Buckingham Institute for Translational Medicine (Clore Laboratory). In the undergraduate Medical School she is the Student Support Lead and Phase 1 Module lead for Metabolism. Claire’s main research focus is on the developmental origins of metabolic disease and potential maternal intervention strategies. Her current interests are the identification of the underlying molecular mechanisms in the regulation of energy balance both centrally and in adipose tissue. But she also has an interest in beta adrenoceptor function, insulin sensitivity in the skin and in the identification of novel metabolic targets including chemerin, AMPK and G-protein-coupled receptors. Claire holds professional membership of Developmental Origins of Health and Disease (DOHaD), European Association for the Study of Diabetes (EASD) and the Association for the Study of Obesity (UK) (ASO). She is on the Editorial board of Frontiers in Epigenomics.
Dr. Moh Tadayyon
Deputy Director, of Metabolic Research, Clore Life Sciences, University of Buckingham
Dr Moh Tadayyon has more than 20 years of healthcare industry experience in the field of metabolic disease research. He has worked in diverse areas including R&D, Medical Affairs and Commercial Strategy groups and as such has been involved across the pharma ‘value chain’ from target identification to Phase 2 clinical trials and from Phase 3b/4 planning to medico-marketing scientific strategy.
Moh has held senior research positions at SmithKline Beecham, GlaxoSmithKline and Boehringer Ingelheim, where he was a member of the Senior Management Team and the Clinical Expert Group in Metabolism and oversaw a portfolio of diabetes and obesity projects. He was directly involved in the identification of several clinical candidates for type 2 diabetes including the DPP-IV inhibitor BI1356 now on the market as linagliptin, arguably the most differentiated in the class.
Moh is currently Deputy Director of the Institute of Translational Medicine at the Clore Lab, University of Buckingham. His interests encompass novel treatment strategies for metabolic and associated diseases (hepatic steatosis, sarcopenia, heart failure and chronic kidney disease) and understanding mechanisms responsible for non-response in type 2 diabetic patients.
Prof Stephanie Taylor
Stephanie Taylor is Professor in Public Health and Primary Care. Her research interests include complex interventions, chronic disease management and the self management of chronic conditions.
She has led a number of systematic reviews of quantitative research evidence and is currently involved in a number of clinical trials of complex interventions in the community. She is principal investigator on an NIHR programme grant looking at a novel self management intervention for chronic musculoskeletal pain (COPERS), and co investigator on a large study of the effect of promoting physical activity on depression amongst residents in residential and nursing homes (OPERA).
Stephanie sits on the NICE Public Health Interventions Advisory Committee. She is an expert advisor on self care of non-communicable diseases to the World Health Organization.
I'm a post-CCT Ophthalmologist, having completed specialty registrar training here at the London Deanery.
Also a Fellow of the Royal College of Ophthalmologists.
Currently working as a Research Fellow at Moorfields Eye Hospital & UCL Institute of Ophthalmology .
I graduated with an MBBS from Imperial College London back in in 2005.
Industry Lead for Health and Care, Digital Advisory Services, Microsoft UK
As an Enterprise Architect in the Digital Advisory Services Practice at Microsoft UK, Paul leads Microsoft’s engagement with Health and Social Care. He has been with Microsoft for 15 years in a number of Public Sector engagements including Ministry of Defence where he led projects in Aerospace and Defence focusing on the use of the internet for secure collaboration.
Paul is currently working with Kent County Council and with a health provider on their Digital Transformation strategies in Health and Social Care, focusing on the implementation of Microsoft’s cloud and connected health platform that embraces personal health records and wearable devices to encourage citizens to engage with their own health and establish new ways of digital engagement with professional health and care.
Prior to Microsoft, Paul worked in NHS IT for 13 years in Health Informatics.
Dr David Thomson
Consultant Clinical Oncologist and Honorary Senior Lecturer, The Christie
Dr Thomson is Consultant Clinical Oncologist and Honorary Senior Lecturer at The Christie in Manchester, with specialist interest in head and neck cancer. He qualified from Oxford University Medical School in 2004, achieving a First Class honours degree in Physiological Sciences (2001). During a two year Doctor of Medicine (MD) research degree at the University of Manchester (2013-2015), he gained excellent clinical and research experience in technical head and neck radiotherapy; and in proton beam therapy, with Fellowships in the United States (Massachusetts General Hospital, 2013; University of Pennsylvania, 2014). He also gained experience in stereotactic ablative radiotherapy for oligometastatic disease at Princess Alexandra Hospital, Brisbane (2015).
Dr Thomson is actively involved in clinical research, part of the Radiotherapy Related Research group at The Christie and Deputy Chief Investigator for the UK phase III NIMRAD trial. He also has an interest in education and was awarded a Postgraduate Certificate in Medical Education with Distinction (2015).
Dr Adrian Tookman
Adrian is a consultant physician in palliative care and medical director at the Marie Curie Hospice, Hampstead, Clinical Director Marie Curie Cancer Care, and Co-Chair of PallE8 (An Integrated Specialist Palliative Care System). Adrian also has honorary roles as a Senior Lecturer University College London and as a consultant of palliative medicine at The Royal Free London Foundation Trust. Adrian’s Research interests include: Survivorship in Cancer Distress in carers of patients receiving specialist palliative care Fatigue in patients with advanced cancer care How patients’ beliefs affect their experiences in palliative care. He is a past president of the Palliative Care Section at the Royal Society of Medicine and Co-chairman of the North London Palliative and Supportive Care Network. Adrian also has a large in-patient and out-patient clinical practice serving the palliative care needs of patients with terminal illnesses.
Marie Curie UK
Dr Zacharias Tsiamoulos
St Mark's Hospital
Dr. Zacharias P. Tsiamoulos currently holds the post of the Senior Clinical Researcher working under the supervision and in tandem with Professor Brian P. Saunders, at Wolfson Unit for Endoscopy at St Mark’s Hospital and Academic Institute. His basic PhD thesis (in molecular mimicry in IBD) and clinical MD (Res) ongoing research in Luminal Gastroenterology (endoscopic excision of complex colorectal polyps: improving outcomes, new endoscopic instruments and techniques) at Imperial College, London have led to a recent appointment (since November 2015) as a Consultant in Gastroenterology/Specialist in Gastrointestinal Endoscopy at East Kent University Hospital Foundation NHS Trust.
Katie is a Specialist Trainee in Ophthalmology within the London Deanery and currently studying for a PhD as a MRC funded Clinical Research Training Fellow at King's College London. Her research interest is myopia and during her PhD she has focused on examining the epidemiology, aetiology and genetic associations of this increasingly common condition.
Mr Roger Wong
Roger Wong is an ophthalmology consultant at St Thomas’ Hospital (London) and Frimley Park Hospital (Surrey) specializing in vitreoretinal surgery. Roger’s interests include: Minimally invasive suture-less vitreoretinal surgery for retinal detachment, macular diseases, diabetic eye disease, inflammatory eye diseases complicated cataract surgery ocular trauma acute retinal necrosis- a rare inflammatory eye condition. Roger has been invited to speak at various national and international conferences. He Wong continues to be extremely active in clinical research, having published over 40 peer-reviewed articles. Roger obtained his first undergraduate degree in Neurobiology at the University of California, Berkeley and his medical degree from St. George’s Hospital Medical School, University of London. His ophthalmic training in the London area included Moorfields Eye Hospital, Kings College Hospital, and St. Thomas’ Hospital. He is also in charge of providing teaching for undergraduate medical students from Kings College, London and subspecialty ophthalmology trainees in vitreoretinal surgery at St Thomas’ Hospital.
Guys & St Thomas’ Hospitals
Mr Malcom Wilson
Malcolm Wilson has been a Consultant Colorectal and Pelvic Oncological Surgeon at The Christie since April 2000, having previously had consultant posts at Macclesfield, Stepping Hill and the University Hospital of South Manchester. He was Director of Surgery at The Christie between 2006 and 2014. He is the Lead Clinician for Colorectal Surgery, joint Lead of the Peritoneal Tumour Service and a member of Pelvic Tumour Team. He is an Honorary Senior Lecturer at the School of Medicine, University of Manchester, and Consultant Appointment Assessor for the Royal College of Surgeons, England. Malcolm trained in London and Manchester with a brief period at the Cleveland Clinic, Fort Lauderdale, Florida. He has research interests in colorectal and anal cancer, peritoneal tumours and post-operative adhesions.
Professor Annie Young
Annie is Professor of Nursing at Warwick Medical School, working clinically in University Hospitals Coventry and Warwickshire. Her research portfolio encompasses the management of thrombosis in cancer patients, symptomatic care including prevention of chemotherapy-associated alopecia and nausea and vomiting. Rehabilitation for cancer patients and new technologies for monitoring side effects of cancer therapies are special interests; Annie is a member of the NCRI Supportive and Palliative Care Clinical Studies Group. She also teaches oncology nursing in sub-Saharan Africa, alongside local nurses.
Prof Azfar Zaman
Professor of clinical cardiology at Freeman Hospital and Newcastle University, Newcastle-upon-Tyne.
Head of Coronary Intervention and Director of the Cardiac Catheter laboratories at Freeman Hospital
Clinical Director for Cardiovascular Research
I completed postgraduate training in cardiology at regional centres in Leeds, London and Cardiff following which
I was awarded a Fulbright Scholarship and a 2 years British Heart Foundation International Fellowship to study vascular biology at Mount Sinai Medical Center, New York.
I have a research interest in patients with atherothrombosis and diabetes with research grants from the British Heart Foundation, Diabetes Wellness Research Foundation, NIHR
I have over 100 peer reviewed publications and
lead a team of 16 individuals conducting clinical trials and research in cardiology.